medline.ch Neurologie Parkinson

	Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases. NPJ Parkinsons Dis Fox SH, Luca DG, Postuma RB, Bhidayasiri R, Cardoso F, Kovacs GG, Katzenschlager R, Trenkwalder C. PMID: 41390531 [PubMed - as supplied by publisher]
	Resistant starch improves Parkinson's disease symptoms through restructuring of the gut microbiome and modulating inflammation. Brain Behav Immun Petrov VA, Schade S, Laczny CC, Hallqvist J, May P, Jäger C, Aho VTE, Hickl O, Halder R, Lang E, Caussin J, Lebrun LA, Schulz J, Unger MM, Mills K, Mollenhauer B, Wilmes P. PMID: 41389850 [PubMed - as supplied by publisher]
	Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial. Lancet Neurol Greenland JC, Dresser K, Cutting E, Donegan R, Bond S, Crisp SJ, Scott KM, Voysey ZJ, Holbrook J, Kahanawita L, Pal R, Camacho M, Peattie ARD, Spindler LRB, Hong YT, Fryer TD, Williams-Gray CH. PMID: 41389828 [PubMed - indexed for MEDLINE]
	The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's disease. Lancet Neurol de Castro Fonseca M, Zanetti L, Fanourakis S, Sulzer DL, Mazmanian SK. PMID: 41389810 [PubMed - indexed for MEDLINE]
	Inter-effort recovery hypoxia did not mitigate acute treadmill effects in people with Parkinson's disease. Parkinsonism Relat Disord Kalva-Filho CA, Zampier VC, Orcioli-Silva D, Faria MH, Papoti M, Barbieri FA. PMID: 41389475 [PubMed - as supplied by publisher]
	Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024. J Mol Med (Berl) Isakovi, Athanassiadis A, Khubeis M. PMID: 41389269 [PubMed - indexed for MEDLINE]
	Yi Jin Jing Exercise Program Improves in Cognition, Sleep and Functional Mobility for Mild and Moderate Parkinson 's Disease: A Randomized Controlled Trial. Exp Aging Res Xiao C, Zhou F. PMID: 41388828 [PubMed - as supplied by publisher]
	Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's disease. Alzheimers Dement Mirza SS, Duff-Canning S, Mapstone M, Fox S, Black SE, Binns MA, Breen DP, Fishman KN, Grimes DA, Lang AE, Levine B, McLaughlin PM, Troyer AK, Masellis M, Marras C. PMID: 41388800 [PubMed - indexed for MEDLINE]
	LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease. Mov Disord Lang AE, Hauser RA, Kalia LV, Hersh B, Berger Z, Arenas RL, Paisan-Ruiz C, Fraser K, Jennings D, Kluss JH, Huntwork-Rodriguez S, Henry AG, Greenamyre JT. PMID: 41388619 [PubMed - as supplied by publisher]
	MDS PD e-Diary: A New Patient-Centered Digital Tool in Development for People with Parkinson's Disease. Mov Disord Clin Pract Rábano-Suárez P, Monje MHG, Vizcarra JA, Paul SS, Avión S, Morse M, Skorvanek M, Tosin MHS, Fuller RLM, Turner TH, Dekker MCJ, Hall DA, Bergmann K, Cedarbaum JM, Maetzler W, Espay AJ, Martínez-Martín P, Stebbins GT, Mestre TA, Sánchez-Ferro Á, MDSe. PMID: 41388609 [PubMed - as supplied by publisher]
	Impulse control disorders and dopamine receptor agonism in Parkinson's disease patients: Clinical implications. Parkinsonism Relat Disord Tangedal NM, Tysnes OB. PMID: 41387037 [PubMed - as supplied by publisher]
	Transcriptomic analysis of plasma small extracellular vesicles identifies potential diagnostic biomarkers for Parkinson's disease dementia. Parkinsonism Relat Disord Rajkumar AP, Hye A, Tan SF, Green H, Killick R, Nizamudeen Z, Isik FB, Figueredo G, Ballard C, Svenningsson P, Aarsland D. PMID: 41385896 [PubMed - as supplied by publisher]
	Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease. Neurology Li CH, Fan SP, Chen PS, Chang YY, Lan MY, Wu YR, Hsiao IT, Chiang HL, Cheng CY, Lee TL, Chang HC, Chang CC, Hsu JL, Huang CW, Lu CS, Lin CH. PMID: 41385755 [PubMed - indexed for MEDLINE]
	A small-scale study on dancing for people living with Parkinson's disease. PLoS One Björkdahl A, Fristedt S, Filipowicz K, Bergman P, Johansson IK, Santos Tavares Silva I. PMID: 41385586 [PubMed - indexed for MEDLINE]
	Safety and feasibility of implementing gym-based strength training for people with early onset Parkinson's disease: a phase 1 trial. Disabil Rehabil Harris DM, Thwaites C, Callisaya ML, Mouer R, Blazé R, Clifford AM, Morris ME. PMID: 41385281 [PubMed - as supplied by publisher]
	Explainable 3D CNNs link regional and network level disruption in early Parkinson's MRIs to symptom progression. bioRxiv Moroze E, Zikopoulos B, Yazdanbakhsh A. PMID: 41383753 [PubMed]
	20â€…Hz beta stimulation of the subthalamic nucleus improves response inhibition in Parkinson's disease. Brain Commun Kricheldorff J, Sauer T, Witt K. PMID: 41383649 [PubMed]
	From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson's disease. Front Immunol Tu R, Han Z, Zhang H, Jia X, Sun T, Liu H, Li J, Tang M, Wang S. PMID: 41383617 [PubMed - indexed for MEDLINE]
	A multimodal MRI framework employing machine learning for detecting beginning cognitive impairment in Parkinson's disease. Front Neurosci Balßuweit K, Bublak P, Finke K, Ruiz-Rizzo AL, Wagner F, Klingner C, Brodoehl S. PMID: 41383382 [PubMed]
	Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co-modified polymer nanoparticles. Neuroprotection Hanumanthappa R, Parthasarathy A, Heggannavar GB, Pc K, Nanjaiah H, Kumbhar R, Devaraju KS. PMID: 41383377 [PubMed]

Artikel 1 - 20 / 55812

Seite 1 von 2791

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung